Alerten

Alerten

ubidecarenone

Manufacturer:

Mega Lifesciences

Distributor:

Maxxcare
Concise Prescribing Info
Contents
Coenzyme Q10
Indications/Uses
25 mg: Supportive treatment for patients w/ CHF. 50 mg: Periodontal disease. Prevention of coenzyme Q10 depletion in concomitant use w/ HMG-CoA reductase inhibitor. Adjunctive therapy for CHF.
Dosage/Direction for Use
25 mg 1 cap daily. 50 mg 1-2 cap bd-tds.
Administration
Should be taken with food.
Contraindications
Severe liver or kidney disease. Pregnancy & lactation. Childn.
Special Precautions
May decrease warfarin effectiveness.
Adverse Reactions
Nausea, diarrhea & epigastric distress particularly w/ higher doses (≥200 mg daily).
ATC Classification
C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Alerten softgel cap 25 mg
Packing/Price
3 × 10's
Form
Alerten softgel cap 50 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in